ClassID:

1931

A01K67/027 - page 2 - CPC Classification

Classification description:

Rearing or breeding animals, not otherwise provided for; New breeds of animals New breeds of vertebrates

Recent Application in this class:
#301
20150307943
2015-10-29

Single nucleotide polymorphisms associated with bull fertility

#302
20150297754
2015-10-22

Animal model of neuronal injury

#303
20150237837
2015-08-27

Non-Human Model for Wound Healing

#304
20150216147
2015-08-06

Genetic test and genetic basis for SCID in pigs

#305
20150125395
2015-05-07

Method for changing condition of an eyelid for evaluation of an eyelid disease involving plugging of meibomian gland orifices and/or telangiectasia by administration of complete freund's adjuvant

#306
20150125394
2015-05-07

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#307
20150047061
2015-02-12

Humanized M-CSF mice

#308
20150024007
2015-01-22

Long term disease modification using immunostimulatory oligonucleotides

#309
20150017664
2015-01-15

Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

#310
20140329291
2014-11-06

Nucleic acids encoding D4 desaturases and D5 elongases

#311
20140317767
2014-10-23

Persistent Inheritance of Hyperdominant Traits in a Perennial Lineage

#312
20140317766
2014-10-23

Antibody producing non-human mammals

#313
20140314755
2014-10-23

Antibody producing non-human mammals

#314
20140304843
2014-10-09

Method for assessment of potential for development of dravet syndrome and use thereof

#315
20140298495
2014-10-02

METHOD FOR OBTAINING A TRIPLOID INTERSPECIFIC HYBRID OF MEAGRE AND RED DRUM

#316
20140237631
2014-08-21

Neurovirulent strain of the West Nile virus and uses thereof

#317
20140230082
2014-08-14

Recombinant constructs and transgenic fluorescent ornamental fish therefrom

#318
20140227266
2014-08-14

Nogo receptor antagonists and methods of increasing neurite outgrowth

#319
20140212893
2014-07-31

L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders

#320
20140178308
2014-06-26

Method for increasing the intraocular pressure in an animal

#321
20140178306
2014-06-26

Steatohepatitis-liver cancer model animal

#322
20140148381
2014-05-29

Modified viral structural protein with antiviral activity

#323
20140130191
2014-05-08

METHODS FOR TREATING IMMUNE-MEDIATED DISEASES OF THE NERVOUS SYSTEM ADMINISTERING A COMPOUND COMPRISING AGENTS THAT INHIBIT PROKINETICIN RECEPTORS ACTIVITY

#324
20140130190
2014-05-08

Transgenic non-human animal model of neurodegenerative disease

#325
20140112923
2014-04-24

Epitope and its use of hepatitis B virus surface antigen

#326
20140086841
2014-03-27

Pig for atrioventricular block model, monkey for atrioventricular block model, guinea pig for atrioventricular block model, and use thereof

#327
20140082758
2014-03-20

Control and Characterization of Psychotic States

#328
20140068797
2014-03-06

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#329
20140056882
2014-02-27

Method of treating pulmonary disease by administering an antibody to G-CSF

#330
20140045711
2014-02-13

Single nucleotide polymorphisms associated with bull fertility

#331
20140041065
2014-02-06

Rodent model of central neuropathic pain caused by dorsal root entry zone avulsion at T13

#332
20130317039
2013-11-28

Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease

#333
20130306000
2013-11-21

Aflaxtoxin Resistant Poultry

#334
20130276159
2013-10-17

Method and culture medium for preparing mammalian ovum or embryo in which zona pellucida has been thinned or eliminated, and method for fertilization using mammalian ovum prepared by same method

#335
20130230520
2013-09-05

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain

#336
20130219535
2013-08-22

Transgenic animals and methods of use

#337
20130219530
2013-08-22

challenge model

#338
20130212720
2013-08-15

Biomarkers associated with autoimmune diseases of the lung

#339
20130196429
2013-08-01

Protein-Free Gamete and Embryo Handling and culture Media Products

#340
20130150663
2013-06-13

System and method for sorting cells

#341
20130149737
2013-06-13

System and method for sorting cells

#342
20130149733
2013-06-13

Establishment of rhesus monkey model of autoimmunity type 1 diabetes

#343
20130145484
2013-06-06

Antibody producing non-human mammals

#344
20130116499
2013-05-09

Method for producing embryos by in vitro culture, and method, apparatus, and system for selecting embryos

#345
20130111612
2013-05-02

Primate model from the family cercopithecidae infected by a HBV strain of human genotype

#346
20130053328
2013-02-28

Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway

#347
20130047274
2013-02-21

CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof

#348
20130042330
2013-02-14

Humanized M-CSF mice

#349
20130036482
2013-02-07

METHOD FOR ASSESSMENT OF POTENTIAL FOR DEVELOPMENT OF DRAVET SYNDROME AND USE THEREOF

#350
20130034624
2013-02-07

ANIMAL MANAGEMENT

#351
20120322096
2012-12-20

Animal stroke model

#352
20120315636
2012-12-13

Method for auxiliary identification of inbred line of wuzhishan miniature pig and its special primer

#353
20120304322
2012-11-29

Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera

#354
20120276013
2012-11-01

GENETICALLY DETERMINED MOUSE MODEL OF RESISTANCE TO TRANSPLANTABLE CANCERS

#355
20120266261
2012-10-18

Neurovirulent strain of the West Nile virus and uses thereof

#356
20120264816
2012-10-18

Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation

#357
20120251528
2012-10-04

Non-Human Mammal Model Of Human Hematopoietic Cancer

#358
20120244632
2012-09-27

Sterol glucoside toxins

#359
20120231545
2012-09-13

METHOD FOR MODIFYING BOVINE EMBRYO STEM CELLS AND METHOD FOR PURIFYING PROTEINS PRODUCED BY MODIFIED BOVINE EMBRYO STEM CELLS

#360
20120227119
2012-09-06

Methods of Modulating the Sex of Avians

#361
20120222142
2012-08-30

Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

#362
20120210449
2012-08-16

Transparent zebrafish and preparation method thereof

#363
20120208753
2012-08-16

Composition and Method for the Treatment or Prevention of Spinal Disorders III

#364
20120184492
2012-07-19

THERAPEUTIC USE OF A GROWTH FACTOR, NSG33

#365
20120164179
2012-06-28

Leishmania challenge model

#366
20120157667
2012-06-21

Methods Of Producing Humanized Non-Human Mammals

#367
20120144510
2012-06-07

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

#368
20120136044
2012-05-31

Compositions And Methods Of Inhibiting NADPH Oxidase Expression

#369
20120128594
2012-05-24

Selective infarcted-tissue-targeting bacteria and use thereof

#370
20120117671
2012-05-10

STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL

#371
20120110683
2012-05-03

NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME

#372
20120107342
2012-05-03

Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method

#373
20120079612
2012-03-29

Dry eye animal model

#374
20120076761
2012-03-29

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease

#375
20120027776
2012-02-02

DIABETIC MODEL

#376
20120015402
2012-01-19

Methods of generating and using antibody-producing cells

#377
20110289608
2011-11-24

Antisense modulation of interleukins 17 and 23 signaling

#378
20110268747
2011-11-03

STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness

#379
20110268705
2011-11-03

HDAC4 nucleic acid administration to treat retinal disease

#380
20110265193
2011-10-27

Identification of mutation and method for detecting lavender foal syndrome in the horse

#381
20110250300
2011-10-13

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS

#382
20110239318
2011-09-29

METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT

#383
20110237514
2011-09-29

PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN

#384
20110236318
2011-09-29

ANIMAL MODEL OF AN EJACULATION-LIKE REFLEX

#385
20110229412
2011-09-22

ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND MEHTODS OF MAKING AND USING THE SAME

#386
20110184043
2011-07-28

Inhibition of angiogenesis

#387
20110183912
2011-07-28

AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR

#388
20110152351
2011-06-23

Modulation of SMRT expression

#389
20110119775
2011-05-19

HYDRAZIDE-CONTAINING CFTR INHIBITOR COMPOUNDS AND USES THEREOF

#390
20110118341
2011-05-19

Long term disease modification using immunostimulatory oligonucleotides

#391
20110110862
2011-05-12

Disease animal model for chronic pain

#392
20110099645
2011-04-28

Animal model for cigarette-smoke-induced atherosclerosis and related methods

#393
20110091425
2011-04-21

Upregulation of opioid receptors for management

#394
20110078803
2011-03-31

Sex selected equine embryo production system

#395
20110061119
2011-03-10

METHOD OF PRODUCING NON-HUMAN MAMMALS

#396
20110059494
2011-03-10

D4 desaturases and D5 elongases

#397
20110034543
2011-02-10

DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus

#398
20110010781
2011-01-13

Production of human antibodies using NOD/SCID/γmice

#399
20100333217
2010-12-30

SCREENING METHOD FOR THE COMPOSITION FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS AND METABOLIC BONE DISEASE USING TALLYHO/JNGJ MOUSE

#400
20100317836
2010-12-16

Biological substance nesfatin and its related substances and uses thereof

#401
20100285049
2010-11-11

Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method

#402
20100275278
2010-10-28

ANIMAL MODEL FOR HIV INDUCED DISEASE

#403
20100273854
2010-10-28

COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION

#404
20100242125
2010-09-23

METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS AND OPTIMIZING PREIMPLANTATION EMBRYONIC DEVELOPMENTAL RATES ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS

#405
20100226940
2010-09-09

Herpes simplex virus mutant ICP0

#406
20100226878
2010-09-09

Methods of inhibiting photoreceptor apoptosis

#407
20100189647
2010-07-29

Experimental Animal As Pathological Model, Method of Producing the Experimental Animal, and Method of Using the Experimental Animal

#408
20100169987
2010-07-01

ANIMAL MODEL SIMULATING NEUROLOGIC DISEASE

#409
20100146647
2010-06-10

Antibody producing non-human mammals

#410
20100145889
2010-06-10

RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM

#411
20100124533
2010-05-20

Large Animal Model for Human-Like Advanced Atherosclerotic Plaque

#412
20100122359
2010-05-13

Sex Selected Equine Intracytoplasmic Sperm Injection Embryo Production System

#413
20100115637
2010-05-06

Models of thrombotic thrombocytopenic purpura and methods of use thereof

#414
20100111910
2010-05-06

Treatment of excessive neovascularization

#415
20100099854
2010-04-22

NEUROVIRULENT STRAIN OF THE WEST NILE VIRUS AND USES THEREOF

#416
20100077498
2010-03-25

COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY IN THE MOUSE

#417
20100069614
2010-03-18

Antibody producing non-human mammals

#418
20100068148
2010-03-18

ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL

#419
20100058488
2010-03-04

PROTEIN FORMULATIONS COMPRISING S1-5

#420
20100050280
2010-02-25

RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM

#421
20100040551
2010-02-18

Rodent model of central neuropathic pain

#422
20100037331
2010-02-11

Recombinant constructs and transgenic fluorescent ornamental fish therefrom

#423
20100034746
2010-02-11

ANIMAL MODEL, SYSTEM, AND METHOD FOR SCREENING COMPOUNDS FOR ANTITHROMBOTIC AND/OR THROMBOLYTIC ACTIVITY

#424
20100017895
2010-01-21

Small animal model for hcv replication

#425
20090324591
2009-12-31

Method of treating pulmonary disease by administering an antibody to G-CSF receptor

#426
20090299083
2009-12-03

Feedstuffs for aquaculture comprising stearidonic acid

#427
20090285785
2009-11-19

External Agent for Treatment of Skin Ulcer

#428
20090263324
2009-10-22

Animal Model With Induced Arrhythmia

#429
20090235372
2009-09-17

Hairless Immunodeficient Mouse Model

#430
20090181915
2009-07-16

TRANSCRIPTION FACTOR ARNTL2 GENE AND EXPRESSION PRODUCTS THEREOF USED IN THE DIAGNOSIS, PREVENTION, AND TREATMENT OF TYPE 1 DIABETES

#431
20090155243
2009-06-18

Mouse model of retinal degeneration

#432
20090105148
2009-04-23

COMPOSITIONS AND METHODS FOR TREATING MYOCARDIAL INFARCTION

#433
20090099078
2009-04-16

Nogo receptor antagonists

#434
20090092588
2009-04-09

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease

#435
20090082263
2009-03-26

DRUG AND METHOD FOR IMPROVING BRAIN FUNCTION

#436
20090068215
2009-03-12

Herpes simplex virus mutant ICP0 protein

#437
20090048207
2009-02-19

Hydrazide-containing CFTR inhibitor compounds and uses thereof

#438
20090025645
2009-01-29

Recombinant constructs and transgenic fluorescent ornamental fish therefrom

#439
20080295191
2008-11-27

Method for producing cloned dog

#440
20080295189
2008-11-27

Construction of Arterial Occlusive Disease Animal Model

#441
20080280831
2008-11-13

Chimeric proteins with phosphatidylserine binding domains

#442
20080267969
2008-10-30

Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway

#443
20080263692
2008-10-23

METHODS FOR CORRECTING MITOTIC SPINDLE DEFECTS ASSOCIATED WITH SOMATIC CELL NUCLEAR TRANSFER IN ANIMALS

#444
20080250512
2008-10-09

Restless Legs Syndrome and Periodic Limb Movement Disorder Model Animal

#445
20080247994
2008-10-09

DNA vaccine

#446
20080216183
2008-09-04

Model of infantile spasm syndrome

#447
20080209580
2008-08-28

Mouse developing visceral fat type obesity and diabetes

#448
20080199462
2008-08-21

Preventing airway mucus production by administration of EGF-R antagonists

#449
20080187537
2008-08-07

Method of producing a nucleic acid encoding an antibody

#450
20080175797
2008-07-24

Preventing airway mucus production by administration of EGF-R antagonists

#451
20080153167
2008-06-26

In vivo amplification of neural progenitor cells

#452
20080152623
2008-06-26

Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)

#453
20080138358
2008-06-12

Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method

#454
20080115231
2008-05-15

Biological substance nesfatin and its related substances and uses thereof

#455
20080108585
2008-05-08

DNA vaccination for treatment of autoimmune disease

#456
20080098491
2008-04-24

MOUSE MODELS TO STUDY CACHEXIA

#457
20080095747
2008-04-24

Promotion of Cell Migration and Axon Regeneration in the Cns

#458
20080092250
2008-04-17

Activity-induced pain in animal model of osteoarthritis

#459
20080069941
2008-03-20

Animals for Conserving N-3 Highly Unsaturated Fatty Acids

#460
20080028478
2008-01-31

Method for Genetic Improvement of Terminal Boars

#461
20070298417
2007-12-27

Constructs for gene expression analysis

#462
20070281890
2007-12-06

Fibroblast Growth Factor-13

#463
20070275026
2007-11-29

Therapeutic use of a growth factor, NsG33

#464
20070271620
2007-11-22

Animal model for type II diabetes mellitus and Syndrome X and methods and uses thereof

#465
20070270330
2007-11-22

Preventing airway mucus production by administration of EGF-R antagonists

#466
20070238649
2007-10-11

Agents for Regulating Adiponectin Receptor Expression

#467
20070231792
2007-10-04

Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders

#468
20070218004
2007-09-20

Method of Identifying Therapeutic Compounds Which Can Be Used for the Treatment and/or Prevention of Infections and Diseases Caused by Human Herpesviruses

#469
20070214510
2007-09-13

Method of determining the susceptibility of a subject to developing insulin-dependent diabetes

#470
20070186289
2007-08-09

Animal model for HIV induced disease

#471
20070185200
2007-08-09

Screen for pre-eclampsia

#472
20070150972
2007-06-28

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses

#473
20070124827
2007-05-31

Type 2 diabetic non-human mammals and methods of use

#474
20070113298
2007-05-17

Genetically determined mouse model of resistance to transplantable cancers

#475
20070099260
2007-05-03

Use of a Composition which Regulates Oxidation/Reduction Reactions Intracellularly and/or Extracellularly in a Staining or Sorting Process

#476
20070086946
2007-04-19

Assay

#477
20070067861
2007-03-22

Cloning pigs using donor nuclei from differentiated cells

#478
20070033668
2007-02-08

Inbred miniature swine and uses thereof

#479
20070026379
2007-02-01

Collection Systems for Cytometer Sorting of Sperm

#480
20070021361
2007-01-25

Methods and materials for modulating trpm2

#481
20070011753
2007-01-11

Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse

#482
20070010657
2007-01-11

Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases

#483
20060286585
2006-12-21

Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases

#484
20060282906
2006-12-14

Non-transgenic rodent model of Alzheimer's disease

#485
20060259992
2006-11-16

Animal models of long QT syndrome and uses thereof

#486
20060258584
2006-11-16

Chimeric proteins with phosphatidylserine binding domains

#487
20060252705
2006-11-09

Sterol glucoside toxins

#488
20060248606
2006-11-02

Mouse model for hepatitis C

#489
20060246432
2006-11-02

Methods and materials for modulating task-3

#490
20060241074
2006-10-26

Methods for treatment of pain

#491
20060234964
2006-10-19

Inducible plasmid vector encoding TGF-β and use thereof

#492
20060174360
2006-08-03

Non-inbred embryonic stem cells having good developmental potential

#493
20060161998
2006-07-20

Non-traumatic model for neurogenic pain

#494
20060130161
2006-06-15

Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes

#495
20060121440
2006-06-08

Low pressure sperm cell separation system

#496
20060107337
2006-05-18

Elimination of endogenous porcine retrovirus

#497
20060101532
2006-05-11

Methods for the identification of compounds for the treatment of Alzheimer's disease

#498
20060093604
2006-05-04

Method of treatment and prophylaxis

#499
20060084623
2006-04-20

DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus

#500
20060064771
2006-03-23

Procedure of genetic recombination for galinaceae hybrids breeding

#501
20060053501
2006-03-09

Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses

#502
20060037091
2006-02-16

Method for producing hypertrophic scarring animal model for identification of agents for prevention and treatment of human hypertrophic scarring

#503
20060021072
2006-01-26

Mouse model for Type II diabetes

#504
20050276804
2005-12-15

Method for preventing or treating cardiac hypertrophy

#505
20050265983
2005-12-01

Methods, nucleic acid constructs and cells for treating neurodegenerative disorders

#506
20050250696
2005-11-10

Nucleic acids encoding truncated soluble tumor necrosis factor

#507
20050239740
2005-10-27

Hydrazide-containing CFTR inhibitor compounds and uses thereof

#508
20050239052
2005-10-27

Cloning of rhadinovirus genome and methods for its use

#509
20050221322
2005-10-06

Multiple closed nucleus breeding for swine production

#510
20050216964
2005-09-29

Swine defective for transmission of porcine endogenous retrovirus and uses thereof

#511
20050210536
2005-09-22

Modulation of brain pathways and function

#512
20050198699
2005-09-08

Knockin non-human animal and tissue-specific MnSOD knockout non-human animal

#513
20050198694
2005-09-08

Truncated fragments of alpha-synuclein in Lewy body disease

#514
20050186545
2005-08-25

Method of constructing spinal injury model monkey and utilization thereof

#515
20050164170
2005-07-28

Neurovirulent strain of the West Nile virus and uses thereof

#516
20050144657
2005-06-30

RhPV as a model for HPV-induced cancers

#517
20050130144
2005-06-16

Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs

#518
20050108785
2005-05-19

Cloning using donor nuclei from differentiated fetal and adult cells

#519
20050102708
2005-05-12

Animal model simulating neurologic disease

#520
20050095643
2005-05-05

Method of generating conditionally expressed mutant cells using expressible antisense sequences

#521
20050081257
2005-04-14

Method of producing non-human mammals

#522
20050074439
2005-04-07

Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease

#523
20050034177
2005-02-10

Genetic modification of male germ cells for generation of transgenic species & genetic therapies

#524
20050026838
2005-02-03

Fibroblast Growth Factor-13

#525
20050022258
2005-01-27

Genetically determined mouse model of resistance to transplantable cancers